Multiple Sclerosis Society of Canada  – Webinar Registration


Hear From The Experts: Epstein-Barr Virus Associated with Development of MS

Tuesday March 29, 2022  3:00PM ET  (1 hour)

12:00PM  PT


1:00 MT




2:00PM CT


3:00PM ET


4:00PM AT


4:30PM NT


The Epstein-Barr virus (EBV) has long been suspected of being an environmental risk factor for multiple sclerosis (MS). A new study from Harvard University presents the most significant evidence to date that EBV is in fact a leading cause or initial trigger for the development of multiple sclerosis (MS). This longitudinal study examined a cohort of 10 million U.S. military personnel over two decades, showing that soldiers who were infected with EBV were 32 times more likely to develop MS. The study’s main author, Dr. Alberto Ascherio, says the findings strongly suggest that the virus is a cause and not a consequence of MS. Join us for this webinar to learn more about the study’s findings and what that may mean for MS research and treatments in the future.

Alberto Ascherio

Professor of Epidemiology & Nutrition, Harvard T.H.Chan School of Public Health

Please note, this webinar will be conducted in English only.


MSSC Disclaimer: The MS Society does not approve, endorse, or recommend any specific product or therapy but provides information to assist individuals in making their own decisions.


If you have any questions please call Laurie Murphy at 306-994-6652 toll free: 1-800-268-7582, or email at: Laurie.Murphy@mssociety.ca


Each person must register individually, Google Chrome is recommended for the best registration and attendance experience.

For the day of the webinar you must use Google Chrome or Firefox web browser.  Mobile devices such as phones or tablets are supported if they are running Android or Apple IOS. Zoom meeting client or app is optional.